FOR PHYSICIANS
More insight.
More informed conversations.
The PARIS® Test combines molecular profiling with functional drug testing of living tumor cells, providing personalized information that can complement other clinical information as you evaluate potential treatment options with your patient.
CHOOSE YOUR PATH
Different roles. Different needs.
Choose the pathway that best matches your role.
Oncologists
Explore clinical evidence, patient eligibility, testing requirements and resources for incorporating PARIS into treatment conversations.
FOR ONCOLOGISTS >
Concierge & Referring Physicians
Understand how PARIS works, when it may be relevant and how to help an appropriate patient connect with their treating oncology team and Cure First.
FOR CONCIERGE & REFERRING PHYSICIANS >
THE PARIS TEST
Functional testing that complements genomic insight.
Genomic profiling identifies molecular alterations that may help inform treatment decisions. PARIS adds functional information by testing living tumor sample against multiple therapies and observing their response.
Together, molecular and functional information can provide complementary insight into an individual patient's cancer.
EXPLORE THE PARIS TEST >
CLINICAL CREDIBILITY
Built for clinical use.
PARIS® is available for clinical use and supported by a growing body of scientific research.
CLIA Certified
Testing is performed through a CLIA-certified laboratory.
50 States
PARIS is available for clinical use in all 50 states.
Live Tumor Sample
Functional testing evaluates the response of living tumor cells.
Peer Reviewed Science
Patients evaluated in a real-world evidence cohort*
DISCUSS A PATIENT
Need help deciding where to start?
Review patient eligibility, sample requirements and the process for ordering and coordinating PARIS® testing.